We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





First-Ever Serology Test Built on Multiparameter Flow Cytometry Platform Differentiates Between COVID-19 Infection and Vaccination Antibodies

By LabMedica International staff writers
Posted on 19 Jul 2021
Print article
Illustration
Illustration
A novel test can measure and track an individual's immune response to the COVID-19 vaccine, now and over time.

FlowMetric Life Sciences Inc. (Doylestown, PA, USA) has launched VaxEffect COVID-19 Vaccine Immune Response Test which will provide a personalized, and clinically accurate readout of a person's COVID-19 specific antibody levels, either generated in response to the COVID-19 vaccine or to prior exposure to the SARS-CoV-2 virus. With simple, repeat testing, changes in these antibody levels can be tracked over time utilizing easy-to-read longitudinal reports, to better inform vaccine-based healthcare decisions and to support the optimal use of booster vaccinations as they become available.

Unlike other antibody tests, VaxEffect is the first COVID serology test built on a multiparameter flow cytometry platform that is designed to differentiate between infection and vaccination based on an antibody profile. Using this proven, powerful, and precise technology, the VaxEffect Test is both 99%+ sensitive and 99%+ specific.

"The VaxEffect test will be especially important for patients with immune compromised conditions such as those fighting cancer, diabetes, auto-immune disorders, or those that are immunosuppressed due to organ transplantation, who may have not generated a strong immune response to the vaccine," said Grant Morgan, Ph.D., General Manager of VaxEffect and EVP of FlowMetric Life Sciences Inc.

Related Links:
FlowMetric Life Sciences Inc.

Gold Supplier
SARS-COV-2 PLUS UK Real Time PCR kit
SARS-COV-2 PLUS UK REALTIME PCR KIT
New
POC Pathogen Detection & Gene Expression System
Sal6830 Mobile Workstation
New
β-hCG Test
RAMP TOTAL β-hCG Test
New
Zika Virus IgM µ-Capture ELISA
https://www.ibl-international.com/en/zika-virus-igm-capture-elisa

Print article
IIR Middle East

Channels

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.